These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22467581)

  • 21. Visual impairment and the useful field of vision.
    Leat SJ; Lovie-Kitchin J
    Ophthalmic Physiol Opt; 2006 Jul; 26(4):392-403. PubMed ID: 16792739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The illuminated high contrast macular grid: a pilot study.
    Achiron LR; Witkin NS; McCarey B; Primo S
    J Am Optom Assoc; 1995 Nov; 66(11):693-7. PubMed ID: 8576534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of visual function with physical outcomes and limitations 5 years later in an older population: the Beaver Dam eye study.
    Klein BE; Moss SE; Klein R; Lee KE; Cruickshanks KJ
    Ophthalmology; 2003 Apr; 110(4):644-50. PubMed ID: 12689880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How does the presence and duration of central visual impairment affect reaching and grasping movements?
    Pardhan S; Gonzalez-Alvarez C; Subramanian A
    Ophthalmic Physiol Opt; 2011 May; 31(3):233-9. PubMed ID: 21410742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optokinetic nystagmus as a measure of visual function in severely visually impaired patients.
    Wester ST; Rizzo JF; Balkwill MD; Wall C
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4542-8. PubMed ID: 17898276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A nationwide population-based survey on visual acuity, near vision, and self-reported visual function in the adult population in Finland.
    Laitinen A; Koskinen S; Härkänen T; Reunanen A; Laatikainen L; Aromaa A
    Ophthalmology; 2005 Dec; 112(12):2227-37. PubMed ID: 16325714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The contribution of peripheral and central vision in the control of movement amplitude.
    Lawrence GP; Khan MA; Buckolz E; Oldham AR
    Hum Mov Sci; 2006 Jun; 25(3):326-38. PubMed ID: 16616964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optic-flow and egocentric-direction strategies in walking: central vs peripheral visual field.
    Turano KA; Yu D; Hao L; Hicks JC
    Vision Res; 2005 Nov; 45(25-26):3117-32. PubMed ID: 16084556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Environmental variables and mobility performance in adults with low vision.
    Kuyk T; Elliott JL; Biehl J; Fuhr PS
    J Am Optom Assoc; 1996 Jul; 67(7):403-9. PubMed ID: 8888866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Saccadic eye movements and face recognition performance in patients with central glaucomatous visual field defects.
    Glen FC; Smith ND; Crabb DP
    Vision Res; 2013 Apr; 82():42-51. PubMed ID: 23485426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients have two eyes!: binocular versus better eye visual field indices.
    Asaoka R; Crabb DP; Yamashita T; Russell RA; Wang YX; Garway-Heath DF
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(9):7007-11. PubMed ID: 21810985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
    Roizen N; Kasza K; Karrison T; Mets M; Noble AG; Boyer K; Swisher C; Meier P; Remington J; Jalbrzikowski J; McLeod R; Kipp M; Rabiah P; Chamot D; Estes R; Cezar S; Mack D; Pfiffner L; Stein M; Danis B; Patel D; Hopkins J; Holfels E; Stein L; Withers S; Cameron A; Perkins J; Heydemann P
    Pediatrics; 2006 Aug; 118(2):e379-90. PubMed ID: 16864640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visual impairment, visual functioning, and quality of life assessments in patients with glaucoma.
    Parrish RK
    Trans Am Ophthalmol Soc; 1996; 94():919-1028. PubMed ID: 8981717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visual loss and visual hallucinations in patients with age-related macular degeneration (Charles Bonnet syndrome).
    Abbott EJ; Connor GB; Artes PH; Abadi RV
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1416-23. PubMed ID: 17325191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mobility performance in glaucoma.
    Turano KA; Rubin GS; Quigley HA
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2803-9. PubMed ID: 10549639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of peripheral visual field loss on representations of space: evidence for distortion and adaptation.
    Fortenbaugh FC; Hicks JC; Turano KA
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2765-72. PubMed ID: 18515599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of grasping movements made by healthy subjects in a 3-dimensional immersive virtual versus physical environment.
    Magdalon EC; Michaelsen SM; Quevedo AA; Levin MF
    Acta Psychol (Amst); 2011 Sep; 138(1):126-34. PubMed ID: 21684505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors influencing self-reported vision-related activity limitation in the visually impaired.
    Tabrett DR; Latham K
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5293-302. PubMed ID: 21613370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of visual field loss and mobility performance in older adults: Salisbury Eye Evaluation Study.
    Turano KA; Broman AT; Bandeen-Roche K; Munoz B; Rubin GS; West S;
    Optom Vis Sci; 2004 May; 81(5):298-307. PubMed ID: 15181354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No evidence of a lower visual field specialization for visuomotor control.
    Binsted G; Heath M
    Exp Brain Res; 2005 Mar; 162(1):89-94. PubMed ID: 15517212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.